Company
Every investor coverage indicates participated in a round Harvard Life Sciences Project raised.
Companies Harvard Life Sciences Project acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Professor Jonathan West | Faculty Director | Forbes Australia |
Stories naming Harvard Life Sciences Project. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of SYMBYX, an Australian medtech firm using light therapy lasers to ease Parkinson's symptoms, naming its high-profile investors including ResMed's Peter Farrell and noting clinical trials underway.